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Open access undPurpose: This review analyses the literature concerning the inﬂuence of the patient position (supine,
prone and prone on a belly board device (BB) on the irradiated small-bowel-volume (SB-V)) and the
resulting morbidity of radiation therapy (RT) in pelvic malignancies.
Methods: A literature search was performed in MEDLINE, web of science and Scopus.
Results: Forty-six full papers were found, of which 33 met the eligibility criteria. Fifteen articles focussed
on the irradiated SB-V using dose volume histograms (DVHs). Twenty-seven articles studied the patient
setup in different patient positions.
This review showed that a prone treatment position can result in a lower irradiated SB-V as compared to
a supine position, but a more signiﬁcant reduction of the SB-V can be reached by the additional use of a
BB in prone position, for both 3D-CRT and IMRT treatment plans. This reduction of the irradiated SB-V
might result in a reduced GI-morbidity. The patient position did not inﬂuence the required PTV margins
for prostate and rectum.
Conclusions: The irradiated SB-V can be maximally reduced by the use of a prone treatment position com-
bined with a BB for both 3D-CRT and IMRT, which might individually result in a reduction of GI-
morbidity.
 2012 Elsevier Ireland Ltd.Open access under CC BY-NC-ND license.
Radiotherapy and Oncology 102 (2012) 325–334In radiation oncology new high precision techniques as intensity
modulated radiotherapy (IMRT) [1–3] and adaptive radiotherapy
(ART) [4–7] get incorporated in daily practise and lead to a better
sparing of critical organs. Despite these new techniques, dose esca-
lation in the irradiation of pelvic malignancies remains limited by
the presence of the small intestine in the irradiated volume and
the expected higher incidence of acute and chronic small bowel
morbidity. The overall incidence of acute and chronic small bowel
complications after pelvic irradiation to a dose of 50 Gy is in the or-
der of 2–9% [8,9]. NTCP modelling studies found the small bowel
volume receiving 15 Gy (V15) [10] and 45 Gy (V45) to be the most
relevant parameters for gastrointestinal (GI) toxicity [11,12]. The
most signiﬁcant association between gastrointestinal (GI) toxicity
and irradiated small bowel volume (SB-V) was found in patient
groups receiving concurrent chemotherapy [13]. In series with
concurrent chemotherapy, the small bowel complication rate
seems doubled and reaches rates as high as 25% [10]. Therefore,
SB-sparing is particularly interesting and challenging in this patient
population.
Furthermore, reduction of radiation induced GI toxicity is
important since surgery might in the future no longer be necessarydiation Oncology, University
roningen, The Netherlands.
ema@umcg.nl (N.M. Sijtsema).
er CC BY-NC-ND license.in certain selected patient groups, if radiation is combined with an
early tumour response evaluation using functional imaging
[14,15]. But, reducing GI toxicity is not the only aim of SB sparing.
Improved SB sparing also permits dose escalation for pelvic irradi-
ation [16], which will consequently allow improvement of the tu-
mour control probability.
Recently, Fiorino et al. [17] and Kavanagh et al. [8] reviewed the
risk of SB toxicity after irradiation. They described several studies
that identiﬁed the quantity of SB-V lying in the treatment volume
as a risk factor inﬂuencing the SB-morbidity after radiotherapy.
The irradiated SB-V can be minimalized by different surgical tech-
niques like clip placement in high risk areas, pelvic reconstruction,
reperitonealization of the pelvic ﬂoor, placement of an omental
sling, retroversion of the uterus or by placing a synthetic prosthesis
under the SB (a removable pelvic spacer). The irradiated small bo-
wel volume can also be minimalized by non-surgical radiothera-
peutical means, including 3D conformal radiotherapy, intensity
modulated radiotherapy (IMRT), adaptive radiotherapy, custom-
ized shielding, a shrinking ﬁeld technique, bladder distention and
optimal irradiation position such as supine, prone or by using a
belly board (BB).
This review focuses on the value of choosing the ideal treatment
position and the use of a belly board device in radiation therapy of
pelvic malignancies and its efﬁcacy to minimise the SB-V in the
treatment volume. Because of concerns about larger setup inaccu-
326 Belly board device in pelvic radiotherapyracy in prone position with and without a BB compared to supine
position, an overview of the literature analysing this question will
be given as well.861 potentially eligible papers, abstract form
815 ineligible
(other subjects)
46 eligible full papers full text
15 original 
studies
evaluating 
the SB-V  
with DVHs
14 studies 
estimating the 
treated SB-V
without DVHs
See discussion
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Search strategy and selection criteria
A literature search was performed in MEDLINE, ISI web of Sci-
ence and Scopus in order to retrieve studies concerning the value
of the treatment position and the use of a belly board device in
the radiotherapy treatment of pelvic malignancies. The following
search terms and synonyms were used: radiotherapy, prone posi-
tion, supine position, belly board, up down table, small bowel dis-
placement device, vacuum bag. Furthermore, the references in the
found papers were screened in order to retrieve additional relevant
papers. To be selected for this review, studies had to fulﬁl to the
following eligibility criteria:
(1) comparison of different radiation treatment positions
including supine, prone and/or prone on a BB in pelvic
irradiation;
(2) evaluation of SB-V with dose volume histograms (DVHs);
(3) a minimal study population of 10 patients.
Articles up to November 2011 were included. Both prospective
and retrospective studies were reviewed. Articles in languages
other than English, German or French were excluded.
More speciﬁcally, the purposes of this review are:
(1) To quantify the SB-V in different treatment positions during
3D-CRT for pelvic malignancies:
a. comparison supine vs prone position;
b. comparison supine vs prone on a BB;
c. comparison prone vs prone on a BB.
(2) To assess the possible advantages of the use of a BB in com-
bination with intensity modulated radiotherapy (IMRT).
(3) To assess the relation between reduction of the volume of
irradiated SB and the morbidity of pelvic irradiation.
(4) Patient setup:
a. To analyse what is known about the optimal BB position in
relation to the anatomy of the patient and the treatment
ﬁelds.
b. To investigate what is known about the differences in setup
accuracy of bony anatomy, pelvic organs and the intra- and
interfraction organ motion between supine and prone
(with and without BB) patient position.
In this review the abbreviation BB refers to all commercial or in-
house developed belly board devices and open table tops. The
notation V5, V10, V15, etc. is used for the volume that receives a
maximum dose of 5, 10 or 15 Gy, etc., respectively. In several re-
viewed papers the authors described a relative reduction of the
SB-V30/40/50 etc. which can be very large at the high dose areas.
For example a reduction of the SB-V50 from 8 to 4 cc corresponds
to a relative volume reduction of 50%, however, the absolute vol-
ume reduction is only 4 cc. Therefore, we have concentrated on
absolute volume differences or relative volume differences with re-
spect to the whole SB-V in this review.27 describing 
the BB position 
or evaluating 
the setup 
accuracy
9
Fig. 1. An overview of the number of papers that were found in the literature
search.Results
Literature search
Using the literature search described, we were able to identify
46 publications, of which 33 full papers met the eligibility criteria.In Fig. 1 an overview of these papers is given. No review article
focusing on the advantages and disadvantages of a BB was found.
There were no studies available that provided level I or II evidence.
Most studies were prospective or retrospective comparative plan-
ning studies. Fifteen articles evaluated the SB-V with DVHs.
Twenty-seven studies described the BB positioning or evaluated
the setup accuracy of bony anatomy and/or the internal motion
of the pelvic organs in prone and supine position. The original
study from Nijkamp et al. was excluded from the review because
the colon was included in the contouring of the bowel [18].1 Quantiﬁcation of SB-V in the treatment volume
1a Comparison supine vs prone position
One study evaluated the irradiated SB-V using dose volume his-
tograms (DVHs). Drzymala et al. [19] evaluated prospectively 19
patients with rectal cancer who received preoperative chemora-
diotherapy. A full bladder protocol was used. Each patient was
scanned twice; ﬁrst in prone position, then supine. The bladder
volume was signiﬁcantly higher in supine position: the mean dif-
ference was 58 cc (p < 0.0001). Comparing SB-V5 and -V10 be-
tween the different treatment plans, an additional volume of 141
and 136 cc of the SB (p < 0.0001) received 5 and 10 Gy in supine
position. There was no signiﬁcant SB-V-difference in V15–V45.1b Comparison supine vs prone on a BB (Table 1)
There were four prospective studies comparing the SB-V in su-
pine with the SB-V in prone position using a BB [20–23]. Three
studies were retrospective analyses [24–26]. One prospective
[20] and two retrospective trials [24,25] studied the use of a BB
in combination with IMRT.
All studies, except Bertelrud et al. [23], included also postoper-
atively treated patients. Two CT-scans per patient were used to
compare the SB-V in the two treatment positions by all investiga-
tors, except for Beriwal et al. [24]. Beriwal et al. compared
Table 1
Overview of eligible original studies comparing the irradiated SB-V between supine and prone position with BB.
Author N Indication Treatment Method Results
Prospective studies
Stromberger
et al. [20]
10 Cervical ca Deﬁnitive or postop
IMRT; 50.4 Gy/1.8 Gy
Two CTs pp – Signiﬁcant decrease in SB-V at V20/30/40/45/50.4 prone by 18–2% of the total
SB-V or 79–4 cc (p < 0.05)
– Mean dose of SB was 25.9 vs 30.2 Gy prone with BB vs supine (p = 0.049)
No uniform use
of oral contrast
RTCT No bladder
ﬁlling
instructions
Martin et al.
[21]
29 Gynaecological
ca
Postop irradiation;
43–56 Gy/1.8 Gy
Two CTs pp – Signiﬁcant decrease of SB-V receiving 100%, 95%, 90%, 80% and 70% of pre-
scribed dose prone with BB by 21–45 cc or 4–8% of total SB-V (p < 0.001–0.035)Oral contrast
With/without RTCT (Bladder ﬁlling
not indicated)
Koelbl et al.
[22]
20 Rectal ca Postop RT; 50.4 Gy/
1.8 Gy
Two CTs pp – Signiﬁcant lower SB-V45.4/V40.3/V30.2/V20.2 prone with a BB (p < 0.001)
– Signiﬁcant mean reduction of overlap between SB-V and PTV in prone position
with a BB by 32.5 cc (p < 0.005)
– Lower median dose to the SB prone with BB (15.4 vs 23.9 Gy) (p < 0.001)
Oral contrast
Median
bladder-V
180–183 cc
Bertelrud
et al. [23]
30 Pelvic
malignancies
Deﬁnitive and postop
RT
Two CTs pp – Overall SB-V-reduction prone with BB at V40/45/50 of 176, 197 and 108 cc
– (p values are not indicated)
– The same patient group was studied by Shanahan et al. [81]
Oral contrast
DB
Retrospective studies
Beriwal et al.
[24]
47 Endometrial ca Postop IMRT; 45–
50 Gy and brachy
10 Gy
One CT pp – Not signiﬁcant reduction of SB-V20/30/40/45 and V50 prone with a BB (ns)
– Not signiﬁcant increase of SB-V10 prone position with a BB (ns)
– (SB prone and supine: comparison between different patients!)
Oral and iv-
contrast
Bladder ﬁlling
not speciﬁed
Adli et al.
[25]
16 Gynaecological
ca
Pre-/postop IMRT;
45 Gy
Two CTs pp – Signiﬁcant reduction of SB-V25–50 prone with BB with limited arc IMRT by 9–
3% of the total SB-V (p = 0.02–0.003)
– Signiﬁcant reduction of SB-V35–45 prone with BB with extended arc IMRT by
4–3% of the total SB-V (p = 0.03–0.04)
Oral and iv-
contrast
Bladder ﬁlling
not indicated
Pinkawa
et al. [26]
20 Gynecological
ca
Deﬁnitive and postop
RT
Brachy in cervical
cancer
Two CTs pp – Signiﬁcant reduction of SB-V receiving 50%, 60% and 90% of the prescribed dose
prone with BB in postop RT only (p < 0.001)
– Signiﬁcant mean reduction of the SB-V receiving 90% of the prescribed dose in
postop RT prone with BB by 13% of the total SB-V (p < 0.001)
Use of contrast
not indicated
Bladder ﬁlling
not indicated
Abbreviations: BB, belly board; brachy, brachytherapy; Ca, cancer; CT, computer tomography; DB, distended bladder; IMRT, intensity modulated radiotherapy; preop/postop,
preoperative/postoperative; pp, per patient; PTV, planning target volume; RT, radiotherapy; RTCT, concurrent radiochemotherapy; SB-V, small bowel volume; SB-V10/20/. . .,
small bowel volume receiving 10/20. . . Gy.
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positions [24]. In the prospective studies a signiﬁcant reduction
of the irradiated SB-V up to 197 cc at V45 was observed for patients
positioned prone on a BB [20–23]. The largest absolute reduction of
the irradiated SB-V was predominantly seen in the low dose areas
of the treatment volume.
1c Comparison prone vs prone on a BB (Table 2)
There were ﬁve prospective studies [27–31] and two retrospec-
tive studies [32,33] comparing the SB-V in a prone treatment posi-
tion with and without the use of a BB. In the prospective studies
and one retrospective study a signiﬁcant average reduction of the
SB-V in the treatment volume was observed by 13–167 cc [27–
31,33]. In the retrospective study of Hollenhorst et al. [32] in which
two different patient groups were compared the difference of the
SB-V reduction did not reach the level of signiﬁcance.
In four studies, two CTs per patient were acquired (with and
without BB) [27,30,31,33]. In the studies conducted by Kim et al.
[28,29] the investigators conducted four CTs per patient: (1) in
prone position with an empty bladder, (2) in prone position using
a BB with an empty bladder, (3) in prone position with a full blad-
der and (4) in prone position on a BB with a full bladder. This made
a separate investigation of the inﬂuence of the bladder ﬁlling
possible.
In preoperatively irradiated patients, Kim et al. [28] found that
the prone position with a full bladder on a BB resulted in the larg-est SB-V reduction of 77 cc at the 50% isodose and of 52 cc at the
90% isodose compared to the reference position (prone with an
empty bladder; mean bladder volume 120 cc). In the prone posi-
tion with a distended bladder (mean bladder volume 607 cc) and
no BB a reduction of 59 cc at the 50% isodose and 43 cc at the
90% isodose was measured compared to the reference position. Fi-
nally, the prone position on a BB with an empty bladder allowed a
SB-V reduction of 45 cc at the 50% isodose and a SB-V reduction of
28 cc at the 90% isodose compared to the reference position.
In another study, Kim et al. [29] measured the same parameters
in postoperatively irradiated patients. A signiﬁcant reduction of the
irradiated SB-V was conﬁrmed at all dose levels (p < 0.001). A mean
reduction of the irradiated SB-V was found for the prone position
on a BB (empty bladder) of 42 cc, for the prone position with a full
bladder of 77 cc and for the prone position on a BB with distended
bladder of 99 cc with respect to the prone position without a BB
and with empty bladder [29].
In conclusion the combination of a full bladder with the use of a
BB shows the best sparing of the SB in pre- and postoperatively
irradiated patients. The SB-V reduction that could be achieved
was comparable for pre- and postoperatively irradiated patients.
Das et al. [31] also found no signiﬁcant inﬂuence of the thera-
peutic sequence (surgery/irradiation) on the content of SB-V in
the treatment volume. A cranial dislocation of the SB of up to
10 cm was measured using a BB compared to the prone position
alone [31].
Table 2
Overview of eligible articles comparing the irradiated SB-V between prone position without and with a BB.
Author N Indication Treatment Method Results
Prospective studies
Kim et al.
[27]
20 Rectal ca IMRT
PREop RT; 50 Gy
Two CTs pp
Oral contrast
Empty bladder
(120 cc)
– Signiﬁcant reduction of the SB-V receiving 20–100% of the prescribed dose prone
with BB by 69–13 cc (p < 0.001–0.012)
Kim et al.
[29]
20 Rectal ca POSTop RT Four CTs pp with/
without DB
Oral contrast
Rectumcontrast
Four groups:
(I) Empty bladder no BB (reference group)
(II) Empty bladder with BB
(III) Full bladder no BB
(IV) Full bladder with BB
– Signiﬁcant reduction of the irradiated SB-V receiving 10–100% of the prescribed
dose in groups II till IV with respect to group I (p < 0.001)
– Mean SBV-reduction of 42 cc; 77 cc and 99 cc in groups II, III and IV with respect to
group I
Kim et al.
[28]
20 Rectal ca PREop RT Four CTs pp with/
without DB
Oral contrast
Four groups:
(I) Empty bladder no BB (reference group)Empty bladder with BB
(II) Full bladder no BB
(III) Full bladder with BB
– Signiﬁcant reduction of the irradiated SB-V receiving 10–100% of the prescribed
dose in groups II till IV with respect to group I (p < 0.05)
– Mean SBV-reduction of 16–80 cc; 22–163 cc and 29–167 cc in groups II, III and IV
with respect to group I
Huh et al.
[30]
10 Cervical
ca
Deﬁnitive RT 45–
50 Gy; brachy
24 Gy
70% RTCT
Two CTs pp
Oral contrast
Bladder ﬁlling not
signiﬁcantly
different
– Signiﬁcant reduction of the irradiated SB-V with BB at all dose levels
– Median reduction of SB-V at the prescription dose with BB of 8.6% of the total SB-V
(p = 0.005)
Das et al.
[31]
12 Rectal ca Pre- and postop RT;
50–62 Gy
10 RTCT
Two CTs pp
Oral contrast
DB
– Signiﬁcant reduction of the SB-V at each dose level prone with BB
– Average reduction of the SB-V receiving 10–100% of the prescribed dose by 81 cc
(184–15 cc)
– In nearly 60% patients no SB in the treatment volume receiving > 40% of the pre-
scribed dose, using a BB
Retrospective studies
Hollenhorst
et al. [32]
20 Rectal ca Pre- and postop RT;
45–54 Gy/1.8 Gy
Sometimes RTCT
One CT pp
Oral contrast
(Bladder ﬁlling not
indicated)
– No signiﬁcant volume difference of SB-V (ns). Different patient groups prone and
prone with BB
– Mean dose reduction to the SB with BB by 7–10% of the prescribed dose (with 3- and
4-ﬁeld-RT, respectively)
Huh et al.
[33]
10 Cervical
ca
IMRT
Deﬁnitive RT; 45–
50 Gy, brachy
24 Gy
70% RTCT
Two CTs pp
Oral contrast
Bladder ﬁlling not
signiﬁcantly
different
– Signiﬁcant reduction of SB-V intersecting with PTV by an average of 53 cc
(p < 0.008)
– At all dose levels (10–105% of the prescribed dose) consistent reduction of the SB-V
(248–4 cc) in BB-assisted IMRT compared to conventional IMRT without BB. SB-V
reduction at 15 and 45 Gy was 210 and 33 cc, respectively
Abbreviations: BB, belly board; brachy, brachytherapy; Ca, cancer; CT, computer tomography; DB, distended bladder; IMRT, intensity modulated radiotherapy; Preop/postop,
preoperative/postoperative; pp, per patient; PTV, planning target volume; RT, radiotherapy; RTCT, concurrent radiochemotherapy; SB-V, small bowel volume; SB-V10/20/. . .,
small bowel volume receiving 10/20. . . Gy.
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All studies included in this review investigated patients with
rectal or gynaecological malignancies. These studies were per-
formed in operated and non operated patients. The SB-V could be
reduced signiﬁcantly by the use of a BB in prone position for these
patient groups (Tables 1 and 2). However, none of the reviewed pa-
pers made a comparison between different types of malignancies.2 Intensity modulated radiotherapy (IMRT)
There were ﬁve studies evaluating the SB-V in different
positions using IMRT (including a total of 103 patients)
[20,24,25,27,33]. Two prospective studies evaluated a total of 30
patients with cervical and rectal cancer [20,27] and three retro-
spective studies treated a total of 73 patients with different gynae-
cological malignancies [24,25,33]. Three studies compared the
supine position with the prone position on a BB [20,24,25,27]
and two studies compared the prone position with the prone posi-
tion on a BB [27,33].2a Comparison of the supine position with the prone position on a BB
(IMRT)
In a prospective study published by Stromberger et al. [20],
treating all patients with IMRT, a signiﬁcant decrease of the
SB-V20/V30/V40/V45 and V50.4 was found using a BB in prone
position (p < 0.05), as compared to supine position. There was a
reduction of the SB-V by 1.5% (V50.4) to 17.7% (V30) correspond-
ing to 8 and 79 cc, respectively. The mean dose to the SB
was 25.9 Gy prone with a BB compared to 30.2 Gy supine
(p = 0.049).
Also in the retrospective studies by Beriwal et al. [24] and Adli
et al. [25] a decreased high dose SB-V was found for patients
treated prone on a BB; the differences (3–9%) were though only
signiﬁcant in the study of Adli et al. The differences were larger
for IMRT plans with a limited arc technique (180 arc) as compared
to an extended arc technique (340 arc), because the irradiated SB-
V was smaller with the extended arc technique [25]. However, for
the SB-V10 Adli et al. found an increase in prone position on a BB
(14%).
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(IMRT)
In the prospective study by Kim et al. [27], a mean reduction of
the SB-V of 13–69 cc at dose levels 20–100% (p < 0.05) was found
using a BB. In this study they used an empty bladder protocol.
Huh et al. [33] measured a signiﬁcant reduction of the SB-V inter-
secting with the PTV in prone position with a BB of on average of
53 cc and a reduction of the SB-V receiving 10–105% of the pre-
scribed dose by 248–4 cc.
With BB-assisted IMRT a further reduction of the SB-V is possi-
ble compared to the use of IMRT alone [20,24,25,27,33]. However,
the beneﬁt of a BB in combination with IMRT was smaller or absent
in low dose areas (<10% of the prescribed dose) in some studies.3 Morbidity
Toxicity was scored in only a few of the above mentioned stud-
ies. However, in these studies the patients were all treated prone
on a BB, since this was considered the ideal position concerning
the SB-sparing. Koelbl et al. [22] calculated a median NTCP and
found a signiﬁcant reduction of the probability of developing mor-
bidity using a BB. With the algorithm of Lyman they calculated an
NTCP value for acute (a/b = 10 Gy) and late (a/b = 2.5 Gy) SB-toxic-
ity (TD50 according to Emami) in supine position of 3.38 and 2.39,
and for prone position on a BB a value of 1.05, and 0.75, respec-
tively (p < 0.001). With the model of Kutcher they found median
NTCP values for acute and late effects of 4.04 and 2.86 for the su-
pine and 1.28 and 0.86 for the prone position, respectively
(p < 0.001).4 Patient setup
4a Optimal position of the BB in relation to the patient and the
treatment ﬁelds
Koelbl et al. [34] and Lee et al. [35] compared three different BB-
positions. Koelbl et al. used a BB aperture with a diameter of 35 cm,
while the lower end of the BB aperture was placed at the lumbosa-
cral joint, the sacro-iliac joint and the symphysis, resulting in
433 cc, 640 cc and 862 cc of the SB-V situated within the longitudi-
nal extension of the treatment volume, respectively. The most opti-
mal displacement of the SB out of the planning target volume (PTV)
was found with the caudal end of the BB-opening located in the
most cranial position. Lee et al. [35] used a BB-opening of
25  25 cm2 and evaluated the SB-V with the lower end of the
BB aperture in the same three positions as described by Koelbl
et al. They found corresponding results for SB-V10 and 20. The irra-
diated SB-V receiving 30% or more of the prescribed dose did not
vary signiﬁcantly while changing the position of the BB-opening.
4b Setup accuracy
In Table 3 an overview of the literature concerning the setup
accuracy in supine and prone (with and without BB) position is gi-
ven. Only three papers compared the setup accuracy of the bony
anatomy with and without a BB [36–38]. Italia et al. [36] found
no signiﬁcant differences between the prone position using a BB
and an immobilisation cast in institute A and the supine position
without a BB or another immobilisation in institute B. Only in
the superior inferior (SI) direction they found a larger percentage
of patients with an average setup error > 5 mm (23% vs 11% supine)
and a larger random setup error (1 SD = 4.2 mm vs 1.8 mm supine)
in institute A. Siddiqui et al. [30] found larger residual setup errors
using an off-line correction protocol (3D vector length 5.4 mm su-
pine and 5.0 mm prone with BB) due to larger random errors in the
supine position as compared to prone position on a BB. Allal et al.
[37] found signiﬁcantly larger average positioning errors for pa-
tients treated in prone position using a BB as compared to pronewithout a BB (up to 4.5 mm with BB and 1.8 mm without BB in
the anterior posterior (AP) direction).
The positioning accuracy of the bony anatomy in prone and su-
pine position was investigated in the papers of Greer et al. [39] and
Weber et al. [40]. Greer et al. found larger mean (5.2 vs 3.3 mm),
random (3.3 vs 2.3 mm) and systematic (4.5 vs 3.7 mm) position
deviations in the AP direction in prone position if tattoo alignment
was used. If the patients were aligned with a ﬁxed height method
they did not ﬁnd signiﬁcant differences. Weber et al. did not ﬁnd
signiﬁcant differences in the mean position deviation and the ran-
dom variation. They only found larger systematic errors in the
prone position with a maximum difference of 4.1 vs 2.2 mm in SI
direction.
A comparison between prone and supine position was made
for the prostate in ten papers [41–50] and for the rectum in a pa-
per by Nijkamp et al. [51]. Four papers [42,43,46,50] described a
larger intrafraction prostate motion in the prone position, espe-
cially in combination with immobilisation casts (0.9–5.1 mm
prone vs 0.1–0.3 mm supine due to breathing motion). Two
papers [44,45] found no signiﬁcant difference in intrafraction
prostate motion between the prone and supine position. Malone
et al. [41] found larger respiratory motion in the prone position
if immobilisation was used. However, this difference was absent
for patients without immobilisation. For the interfraction prostate
motion, only small differences were observed between prone and
supine position. Furthermore the interfraction shape variation of
the mesorectum was comparable in prone and supine position
[51].
Stroom et al. [52] compared the internal prostate motion and
the required margins for the planning target volume (PTV) for
the supine position and the prone position on a BB. They found
similar PTV margins of 1 cm in AP and SI direction and 0.5 cm in
the lateral direction for both patient positions. Liu et al. [49] state
that 0.5 cm margins are appropriate for the prostate in both supine
and prone position if soft tissue alignment is used. Nijkamp et al.
[51] investigated PTV margins required for the rectum in prone
and supine position after online setup correction based on bony
anatomy. They found comparable margins for prone and supine
position but found differences between male and female patients
(up to 1.7 and 2.3 cm for male and female patients in the prone
and up to 1.9 and 2.4 cm for male and female patients in the supine
position).Discussion
Comparing the supine with the prone treatment position (with-
out a BB) a reduction of the SB-V is probable in prone position [19].
This was also demonstrated by other authors [53–57]. However, in
these papers the SB-V was evaluated with orthogonal radiographs
instead of DVHs and therefore, they were not included in this re-
view. A larger reduction of the SB-V can be obtained by the addi-
tional use of a BB in prone position compared to both supine
[20–26] and prone position alone [27–33]. In the prospective stud-
ies the SB-V reduction by a BB compared to prone position alone
was 13–167 cc [27–31]. This was conﬁrmed in other studies that
were not included in this review because these studies evaluated
the SB-V with orthogonal radiographs instead of DVHs or included
too few patients [56,58–66].
IMRT has shown to reduce the SB-V receiving the prescribed
dose in pelvic RT by 50% compared to 3DCRT [11,67,68]. Using
BB-assisted IMRT a further reduction of the SB-V is observed
[20,24,25,27,33]. The beneﬁt of a BB in combination with IMRT
was smaller or even absent in very low dose areas (<10 Gy). This
ﬁnding can be expected as IMRT is known to result in larger areas
irradiated with low doses. The clinical signiﬁcance of these very
Table 3
Overview of papers describing the setup errors of the bony anatomy and internal motion of pelvic organs in prone (with and without BB) and supine position.
Paper Patient position
comparison
No. of patients Method Correction
protocol
used
Intra or
interfraction
motion
Setup
error of
Results
Italia et al.
[36]
Prone with BB and
immobilisation in
institute A vs supine
in institute B
30 prone and
22 supine
Portal ﬁlms No Inter Bony
anatomy
Only in SI direction: a larger mean setup
error (23% of patients > 5 mm vs 11%) and a
larger random error (1 SD: 4.2 mm vs
1.8 mm) for the prone position with BB
Allal et al.
[37]
Prone with BB vs
prone without BB
14 prone with
BB and 9 prone
without BB
Portal ﬁlms No Inter Bony
anatomy
Signiﬁcantly larger average positioning
errors for patients treated prone on a BB
compared to prone without BB. Largest
differences in the AP direction (4.5 vs
1.8 mm)
Siddiqui
et al. [38]
Prone with BB vs
supine
11 prone and
19 supine
MVCBCT Off-line
protocol
Inter Bony
anatomy
Larger residual setup error in supine position
due to larger random errors (5.4 vs 5.0 mm
3D vector length)
Greer et al.
[39]
Prone vs supine and
tattoo vs ﬁxed height
(AP direction only)
8 prone and 11
supine
Portal ﬁlms No Inter Bony
anatomy
Tattoo alignment: larger mean deviation (5.2
vs 3.3 mm), random (3.3 vs 2.3 mm) and
systematic position variation (4.5 vs
3.7 mm) in the prone vs supine position
Fixed height alignment: no signiﬁcant
difference in mean deviation (0.1 vs
0.4 mm), random (1.2 vs 1.3 mm) and
systematic position variation (1.1 vs
1.2 mm) in the prone vs supine position
Weber et al.
[40]
Prone vs supine 12 prone and
10 supine
Portal ﬁlms No Inter Bony
anatomy
No differences in average position deviation
and random errors. Only systematic errors
larger in the prone position (4.1 vs 2.2 mm)
SI and (2.7 vs 1.9 mm) AP
Malone
et al. [41]
Prone with and
without
immobilization and
supine
20 patients in
three different
positions
Fluoroscopy + f.m. n.a. Intra
(breathing)
Prostate In immobilized prone patients the mean
total displacement was 3.3 ± 1.8 (SD) mm.
Larger breathing motion with
immobilization in the SI and AP directions
than without immobilization. No difference
between supine and prone without
immobilization
Dawson
et al. [42]
Prone with 2 different
immobilisation
methods, supine with
ﬂat and false table
4 patients in
four different
positions
Fluoroscopy + f.m. n.a. Intra
(breathing)
Prostate Larger breathing motion in prone position
especially with immobilisation devices.
Breathing motion 0.9–5.1 mm SI and up to
3.5 mm AP in prone position, <0.1 mm in
supine position
Kitamura
et al. [43]
Prone and supine 10 patients in
two different
positions
Tumour
tracking + f.m.
n.a. Intra
(breathing)
Prostate Larger average amplitude of the internal
prostate motion in prone position (0.5–
1.6 mm) than in supine position (0.1–
0.3 mm)
Bittner et al.
[44]
Prone with
immobilization
comparison with
supine results from
Langen et al. [82]
17 patients
prone with
immobilisation
Calypso
localisation
system
n.a. Intra Prostate Comparable intrafraction motion in prone
(3D displacementP 3 mm andP 5 mm in
13.9% and 1.5% of time) and supine position
(3D displacementP 3 mm andP 5 mm in
13.2% and 3.1% of time)
Shah et al.
[50]
Prone and supine 20 patients
both prone and
supine
Calypso
localisation
system
n.a. Intra Prostate The prostate was displaced > 3 and > 5 mm
for 37.8% and 10.1% of the time in prone and
for 12.6% and 2.9% of the time in supine
position: mostly in the inferior and posterior
direction. For larger displacements (>7 mm)
no differences were observed
Wilder et al.
[45]
Prone and supine 15 patients in
two different
positions
Pre and post
treatment
EPIs + f.m.
n.a. Intra Prostate No signiﬁcant difference in intrafraction
movement between prone and supine
(mean = 2 mm; 1 SD = 1.2–2.0 mm in AP and
SI direction)
Vargas et al.
[46]
Prone and supine
with and without a
rectal balloon (r.b.)
4 patients in
four different
combinations
Cine-MRI n.a. Intra Prostate The 3D intrafraction motion (SD) was 0.6
and 1.2 mm for the supine position with and
without r.b. and 1.5 and 2.2 mm for the
prone position with and without r.b.
Bayley et al.
[47]
Supine and prone
both with
immobilisation
28 patients in
two different
positions
Lateral portal
ﬁlms + f.m. after
on-line correction
On-line on
bony
anatomy
action level
3 mm
Inter Prostate More on-line position corrections in prone
position because of larger deviations bony
anatomy. No signiﬁcant differences in mean
position deviation prostate: in AP direction
0.1 ± 3.3 (SD) mm supine vs 0.5 ± 2.5 mm
prone and in SI direction 1.1 ± 3.8 mm
supine vs 1.3 ± 4.6 mm prone
McLaughlin
et al. [48]
Supine and two prone
(ﬂat and angled table)
positions
10 patients in
three different
positions
CT-scans:
pretreatment and
after 5 weeks
n.a. Inter Prostate No signiﬁcant differences in prostate
position observed: average c.o.m. shift
6.1 mm in supine and 6.2 mm in prone ﬂat
position
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Table 3 (continued)
Paper Patient position
comparison
No. of patients Method Correction
protocol
used
Intra or
interfraction
motion
Setup
error of
Results
Stroom
et al. [52]
Supine and prone on
a BB position
15 patients
supine and 15
prone on a BB
One pre-
treatment and
three repeated
CT-scans
n.a. Inter Prostate Smaller random (r = 1.7 mm AP and 1.5 mm
SI) but larger systematic variations
(R = 3.3 mm AP and 2.2 mm SI) in prone
patients than supine patients (r = 2.8 mm AP
and 2.5 mm SI and R = 2.5 mm AP and
2.7 mm SI) resulting in similar PTV margins
for the two treatment positions (1 cm AP and
SI and 0.5 cm lateral). In supine position
time trends caused a signiﬁcant systematic
ventral-superior shift
Liu et al.
[49]
Supine and prone
position
20 patients in
supine or
prone position
Ten repeated CT-
scans
Different
image
guidance
strategies
Inter Bony
anatomy
and
c.o.m.
prostate
Using soft tissue alignment and 0.5 cm
margins adequate CTV coverage both in
prone and supine position. Worse CTV
coverage with bony alignment; better CTV
coverage for prone than for supine positions
Nijkamp
et al. [51]
Supine comparison
with prone results
from Nijkamp et al.
[83] both on a ﬂat
table
28 patients in
supine and 27
in prone
position
Five daily CBCT’s CBCT’s
before on-
line
correction
Inter Rectum Large systematic (1–8 mm (1SD)) and
random (1–5 mm) shape variations of the
mesorectum comparable to prone patients.
Larger differences between male and female
patients than between supine and prone
positions. Proposed margins for the upper
half of the mesorectum up to 1.7 and 2.3 cm
for male and female patients in prone
position and up to 1.9 and 2.4 cm for male
and female patients in supine position
Abbreviations: AP, anterior posterior; CBCT, Conebeam-CT; SI, superior inferior; c.o.m., center of mass; EPI, Electronic Portal Images; f.m., ﬁducial marker; MVCBCT, Mega-
voltage Conebeam-CT; n.a., not applicable; r.b., rectal balloon; 3D, three-dimensional.
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late induction of second cancers [2].
A full bladder, as a natural spacer, might also inﬂuence the irra-
diated SB-V. Two studies showed that a full bladder by itself re-
duces the SB-V in the treatment volume [28,29]. In many of the
reviewed publications the bladder ﬁlling protocol used was not
mentioned, which is an important limitation of these studies.
Keeping the bladder ﬁlling constant is a challenge and can lead
to signiﬁcant changes of the bladder volume during an irradiation
course [69–72]. Speciﬁc instructions for bladder ﬁlling/emptying
help to minimise differences in bladder ﬁlling [71].
Therapeutical sequence
Postoperative the pelvic anatomy has changed, with conse-
quently repositioning of the SB.
The question rises whether SB sparing still occurs in patients
with previous surgery. One prospective study by Gallagher et al.
[54] and three retrospective studies [55–57] observed a similar
SB-V reduction in patients with and without previous surgery.
Therefore, the gain of the use of a BB seems to persist in postoper-
atively irradiated patients. Kim et al. also found in their prospec-
tive studies a signiﬁcant reduction of the irradiated SB-V by
using a BB in both the pre- and postoperatively treated patient
groups [28,29]. Furthermore, Capirci et al. [63] observed in a retro-
spective study a signiﬁcantly higher mobilisation of SB loops
prone on a BB compared to the prone position alone (17 vs 25%,
p < 0.05) in 345 patients treated in an adjuvant setting. However,
Fu et al. [59] found no advantage in the patient group with previ-
ous surgery.
So far, we have seen that the irradiated SB-V can be reduced by
the use of a full bladder protocol, prone position and a belly board,
both using 3D-CRT or IMRT, in pre- and postoperatively irradiated
patients. The clinical relevance, on the other hand, depends on the
complication risks which are related to the absolute amount of SB-
V in the treated volume.Clinical relevance of the irradiated SB-V
Acute small bowel toxicity
Baglan et al. [10] generated a threshold-type model of acute
small bowel toxicity relating the SB-V receiving 15 Gy or less to
the risk of developing grade III GI-toxicity. They found a strong
relationship between the SB-V receiving at least 15 Gy and the de-
gree of acute small bowel toxicity in a rectal cancer patient group
receiving chemoradiation. Mainly grade 0–1 toxicity was seen after
irradiation with a V15 of less than 150 cc (grade 0–I in 90%, grade 2
in 10% of the patients). However, 70% of the patients with a V15 of
more than 300 cc experienced grade 3 toxicity.
The model of Baglan et al. was later validated by Robertson et al.
[73]. They demonstrated that even reducing the areas of SB receiv-
ing a low dose can diminish the complication rate signiﬁcantly (Ba-
glan–Robertson threshold model) [8,10,73].
Roeske et al. found a signiﬁcant correlation between the
amount of SB receiving 45 Gy and acute grade III toxicity in their
multivariate analysis (Roeske-threshold-model) [8,12]. This study
population consisted of 50 gynaecological patients, who were trea-
ted with whole pelvis IMRT consisting of 45 Gy in fractions of
1.8 Gy. They ﬁtted their data in a NTCP model. The risk of acute
GI toxicity was 1.8% for SB-V of 100 cc receiving 45 Gy, while after
irradiation of a 200 cc SB-V with a similar dose the risk was 9.9%.
The above mentioned authors found different thresholds, which
might be explained by the differences in contouring of the SB.
Roeske et al. contoured the entire potential space of small-bowel
location (the peritoneal cavity) while Baglan et al. and Robertson
et al. contoured the single SB-loops. Interestingly Gunnlaugsson
et al. [74] compared in a small retrospective study with 20 patients
different contouring methods and found a strong correlation
between the occurrence of acute toxicity and the irradiated small
bowel loops. No signiﬁcant correlation could be demonstrated for
the drawn ‘‘abdominal space’’. It is therefore recommended to con-
tour the SB-loops instead of an ‘‘abdominal space’’.
That a reduction of SB-V effectively results in reduced gastroin-
testinal toxicity was conﬁrmed in a retrospective study by Samu-
332 Belly board device in pelvic radiotherapyelian et al. [7]. Both grade 2 of higher diarrhea (7 vs 29 patients,
p = 0.02) and enteritis (2 vs 18 patients, p = 0.015) were reduced
in patients treated supine with IMRT as compared to prone on a
BB with CRT. The overall gastrointestinal toxicity was reduced from
62% in the CRT-group to 32% in the IMRT-group (p = 0.006) [7]. This
reduction of acute gastrointestinal toxicity correlated not only to
the SB-V45 but also to the lower mean irradiation dose [7]. This
clinical observation conﬁrms the ﬁndings of the above described
models and stresses the importance to continue to try to reduce
also SB-V receiving low doses of irradiation.Late small bowel toxicity
Reduction of the irradiated SB-V will also inﬂuence the late
small bowel toxicity. In studies with a median follow-up of
16 months (10–24 months) and a minimal follow-up of 2 years,
respectively, Gallagher et al. and Letschtert et al. conﬁrmed a cor-
relation of late bowel toxicity (chronic diarrhea and small bowel
obstruction) with the irradiated SB-V and the dose given to the
SB-V [54,75]. A remarkable increase of late toxicity was seen in
SB-V irradiated with 45 Gy or more.
In conclusion, the clinical relevance of the gain of a BB depends
on the absolute small bowel volume close to the target volumes in-
stead of on treatment indications. For example, in preoperative
rectal cancer radiotherapy, treating only the mesorectum and the
internal iliacal nodes, the irradiated SB-V will generally remain be-
low the threshold for toxicity. Depending on the chosen treatment
schedule and the individual anatomy of a patient treated for a rec-
tal cancer a BB can result in reduction of gastrointestinal toxicity
through better sparing of the SB.
For postoperative cervical cancer, typically larger treatment vol-
umes are contoured, including the obturator and often the iliac
nodes. In patients treated for these indications the irradiated SB-
V will in general be much larger. Therefore the gain of the use of
a belly board is expected to be greater in the latter patient group.
Fu et al. [59] found indeed in his analysis of 51 patients with
gynaecological and gastroenterological pelvic malignancies a sig-
niﬁcant reduction of the SB-V only in gynaecological malignancies
and not in rectal cancer. This study is not included in this review
because the SB-V is evaluated with orthogonal radiographs instead
of DVHs.
The position of the BB in relation to the irradiated volume is
important to obtain a maximal SB-V reduction. The highest SB-V-
reduction is seen placing the lower end of the BB-aperture at the
lumbosacral joint which corresponds to an area close to the upper
end of the PTV.Patient set-up
Almost all papers that investigated the differences between the
setup accuracy of the bony anatomy in supine and prone (with and
without a BB) position found larger mean setup errors and system-
atic position variations in the prone position. It is questionable
how relevant this is, since the mean setup error and systematic
positioning errors can easily be corrected for by the use of off-line
correction protocols like the no action level protocol (NAL) [76] or
the shrinking action level protocol (SAL) [77]. With on-line correc-
tion protocols also the random interfraction setup errors can be
corrected. There is no clear indication for larger residual setup er-
rors of the bony anatomy for the prone position with or without a
BB if position correction protocols are used.
The internal motion of the pelvic organs can be of the same or-
der of magnitude as the setup errors of the bony anatomy [52,78–
80]. For the prostate, the interfraction organ motion can easily becorrected for by using on-line correction protocols in combination
with ﬁducial markers or soft tissue alignment. Therefore, the main
question is whether the intrafraction internal motion depends on
the patient position. Four papers described a larger [42,43,46,50]
and two an equal intrafraction prostate motion [44,45] in prone
compared to supine position. Therefore, no general conclusions
can be drawn from these papers. Probably the results were inﬂu-
enced by the limited number of patients used in some studies
and the differences in treatment protocols between the different
institutes.
The PTV margins, required to account for setup errors and inter-
nal prostate motion, did not depend on the patient position. Mar-
gins of 0.5–1 cm in the AP and SI direction and 0.5 cm in the
lateral direction were recommended [49,52].
For the rectum on-line correction protocols based on bony
alignment can be used. However, still large (1.7–2.4 cm) PTV mar-
gins are required to account for the inter- and intrafraction shape
variations of the mesorectum and other uncertainties in the proce-
dures. Nijkamp et al. have shown that the required margins do not
depend on patient position but do depend on gender [51].Conclusions
The results of this review showed that a prone treatment posi-
tion combined with a BB resulted in a lower irradiated SB-V as
compared to the supine position or the prone position alone. This
SB-V-reduction is seen in pre- and postoperatively irradiated pa-
tients, is valid for both 3D-CRT and IMRT treatment plans and
might result in a reduced GI-morbidity. However the expected gain
varies between patients. Therefore, the clinical relevance should be
evaluated individually based on the absolute reduction of the SB-V
in relation to the NTCP models. A full bladder helps to further re-
duce the SB-V; bladder ﬁlling instructions should be given. The pa-
tient position did not inﬂuence the required PTV margins for
prostate and rectum. The highest SB-V-reduction is seen by placing
the lower end of the BB-aperture around the upper end of the PTV.Conﬂict of interest statement
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